FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and concerns the use of (1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxyphenyl]ethanol) in the form of an R-enantiomer or a pharmaceutically acceptable salt or ester thereof, or a pharmaceutically acceptable salt of such an ester, for the treatment of a patient suffering from a psychiatric disorder. Pharmaceutical composition comprising said active substance is also provided.
EFFECT: group of inventions provides treatment for a patient suffering from a mental illness, due to the developed treatment regimen.
8 cl, 1 tbl, 1 ex
